World's Best Scientists 2026 revealed!
Mario A. Ostrowski

Mario A. Ostrowski

D-Index & Metrics

Immunology

D-Index
68
Citations
18044
World Ranking
2576
National Ranking
56

Mario A. Ostrowski publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mario A. Ostrowski sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 207 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mario A. Ostrowski D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mario A. Ostrowski sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mario A. Ostrowski is affiliated with the University of Toronto in Canada. Their research predominantly focuses on Medicine and Immunology and Microbiology, with a significant number of publications in the infectious diseases subfield, as well as Immunology, Molecular Biology, Virology, and Epidemiology.

The main topics of their work include SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, HIV research and treatment, animal virus infections studies, SARS-CoV-2 detection and testing, immunotherapy and immune responses, and immune cell function and interaction.

Ostrowski's recent papers highlight important aspects of the immune response related to SARS-CoV-2 and COVID-19:

  • Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients, 2020, Science Immunology
  • Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein, 2020, Nature Medicine
  • Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection, 2022, Mucosal Immunology
  • A simple protein-based surrogate neutralization assay for SARS-CoV-2, 2020, JCI Insight
  • Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, 2020, Clinical Infectious Diseases

Frequent co-authors in Ostrowski's work include Patrick Budylowski, Allison McGeer, Anne-Claude Gingras, Samira Mubareka, and James M. Rini, reflecting a collaborative approach in their research efforts.

Their work has been published multiple times across a variety of scientific venues, including bioRxiv (Cold Spring Harbor Laboratory), The Journal of Immunology, Journal of Virology, Nature Communications, and SSRN Electronic Journal.

Ostrowski's publication record shows a consistent focus on infectious diseases and immunology, contributing substantial research in areas related to viral infections and immune response mechanisms.

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Mechanism of hard-nanomaterial clearance by the liver

    Kim M. Tsoi;Sonya A. Macparland;Xue Zhong Ma;Vinzent N. Spetzler

  • Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

    R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth

  • Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.

    Baweleta Isho;Kento T. Abe;Kento T. Abe;Michelle Zuo;Alainna J. Jamal;Alainna J. Jamal

  • CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

    Yu-Hwa Huang;Chen Zhu;Yasuyuki Kondo;Ana C. Anderson

  • Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.

    Seth J. Zost;Pavlo Gilchuk;Rita E. Chen;James Brett Case

  • Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

    Tae Wook Chun;Richard T. Davey;Mario Ostrowski;J. Shawn Justement

  • Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

    Sharilyn K. Stanley;Mario A. Ostrowski;Jesse S. Justement;Kira Gantt

  • Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection

    Unknown

  • TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

    Glen M. Chew;Tsuyoshi Fujita;Tsuyoshi Fujita;Gabriela M. Webb;Benjamin J. Burwitz;Benjamin J. Burwitz

  • Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.

    Tae Wook Chun;J. Shawn Justement;Danielle Murray;Claire W. Hallahan

  • Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors

    Sharif B. Missiha;Mario Ostrowski;E. Jenny Heathcote

  • Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals

    Mario A. Ostrowski;Tae Wook Chun;Shawn J. Justement;Ivette Motola

  • Expression of Chemokine Receptors CXCR4 and CCR5 in HIV-1-Infected and Uninfected Individuals

    Mario A. Ostrowski;Shawn J. Justement;Andrew Catanzaro;Claire A. Hallahan

  • Distinct Transcriptional Profiles in Ex Vivo CD4+ and CD8+ T Cells Are Established Early in Human Immunodeficiency Virus Type 1 Infection and Are Characterized by a Chronic Interferon Response as Well as Extensive Transcriptional Changes in CD8+ T Cells

    Martin D. Hyrcza;Colin Kovacs;Mona Loutfy;Roberta Halpenny

  • CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction.

    Audrey Kinter;Andrew Catanzaro;JoAn Monaco;Margaret Ruiz

  • Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes

    Richard Brad Jones;Rachel O'Connor;Stefanie Mueller;Maria Hottelet Foley

  • Phenotype Determines Nanoparticle Uptake by Human Macrophages from Liver and Blood.

    Sonya A. MacParland;Kim M. Tsoi;Ben Ouyang;Xue-Zhong Ma

  • A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis

    C J Kim;A Nazli;O L Rojas;D Chege

  • A simple protein-based surrogate neutralization assay for SARS-CoV-2.

    Kento T. Abe;Zhijie Li;Reuben Samson;Payman Samavarchi-Tehrani

  • Dendritic Cells Express Multiple Chemokine Receptors Used as Coreceptors for HIV Entry

    Andrea Rubbert;Christophe Combadiere;Mario Ostrowski;James Arthos

Frequent Co-Authors

Colin Kovacs
Colin Kovacs University of Toronto
Rupert Kaul
Rupert Kaul University of Toronto
Douglas F. Nixon
Douglas F. Nixon Cornell University
Allison McGeer
Allison McGeer University of Toronto
Lishomwa C. Ndhlovu
Lishomwa C. Ndhlovu Cornell University
Anne-Claude Gingras
Anne-Claude Gingras Lunenfeld-Tanenbaum Research Institute
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Jonah B. Sacha
Jonah B. Sacha Oregon Health & Science University
Bruce D. Walker
Bruce D. Walker Harvard University
Steven G. Deeks
Steven G. Deeks University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can expand career opportunities. Many students begin with foundational nursing programs that offer flexible online options. For example, online nursing programs for non nurses provide an accessible pathway for individuals without a healthcare background to enter the nursing field.

Accelerated routes are popular among motivated students looking to fast-track their careers. Programs like accelerated nurse practitioner programs allow learners to gain advanced qualifications in less time, preparing them for specialized roles in patient care and research.

For those starting a nursing career, selecting programs with high acceptance rates can ease the application process. Resources on absn programs with high acceptance rates offer guidance on finding Accelerated Bachelor of Science in Nursing programs that are more accessible.

Similarly, prospective Licensed Practical Nurses (LPNs) may benefit from exploring which lpn programs are easiest to get into, helping them to choose pathways that align with their career goals in clinical settings.

Best Scientists Citing Mario A. Ostrowski

Trending Scientists

Recently Published Articles